ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 178 filers reported holding ROCKET PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,888,652 | +4.7% | 288,801 | +2.1% | 0.02% | 0.0% |
| Q2 2023 | $5,621,899 | +29.3% | 282,934 | +11.5% | 0.02% | +21.4% |
| Q1 2023 | $4,347,782 | -11.7% | 253,811 | +0.8% | 0.01% | -12.5% |
| Q4 2022 | $4,925,730 | -10.3% | 251,698 | -35.6% | 0.02% | -20.0% |
| Q3 2022 | $5,489,000 | +13.6% | 390,930 | +5.4% | 0.02% | +17.6% |
| Q2 2022 | $4,831,000 | +47.0% | 370,749 | +79.0% | 0.02% | +88.9% |
| Q1 2022 | $3,286,000 | -22.0% | 207,174 | +7.4% | 0.01% | 0.0% |
| Q4 2021 | $4,212,000 | +44.9% | 192,929 | +98.4% | 0.01% | +28.6% |
| Q3 2021 | $2,907,000 | -32.2% | 97,265 | +0.5% | 0.01% | -36.4% |
| Q2 2021 | $4,287,000 | +3.9% | 96,801 | +4.1% | 0.01% | 0.0% |
| Q1 2021 | $4,126,000 | -20.9% | 92,990 | -2.3% | 0.01% | -21.4% |
| Q4 2020 | $5,217,000 | – | 95,135 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RTW INVESTMENTS, LP | 16,812,491 | $234,534,000 | 10.10% |
| TANG CAPITAL MANAGEMENT LLC | 2,965,485 | $41,369,000 | 5.81% |
| Ghost Tree Capital, LLC | 650,000 | $9,068,000 | 2.40% |
| Boxer Capital, LLC | 1,466,051 | $20,451,000 | 1.39% |
| Vivo Capital, LLC | 860,648 | $12,006,000 | 1.09% |
| Samsara BioCapital, LLC | 128,197 | $1,788,000 | 1.03% |
| Cormorant Asset Management, LP | 1,568,550 | $21,881,000 | 1.02% |
| Perceptive Advisors | 2,189,010 | $30,537,000 | 0.80% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,677,367 | $23,399,000 | 0.74% |
| Eventide Asset Management | 1,415,000 | $19,739,000 | 0.64% |